US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kazia Therapeutics Limited

13.58

-3.3200-19.64%

Post-market: 13.920.3425+2.52%19:30 EDT

Volume:1.18M

Turnover:16.97M

Market Cap:155.18M

PE:-1.99

High:15.50

Open:15.48

Low:13.30

Close:16.90

52wk High:17.40

52wk Low:4.86

Shares:11.43M

Float Shares:9.08M

Volume Ratio:4.24

T/O Rate:12.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.8190

EPS(LYR):-12.3849

ROE:-106.90%

ROA:-25.70%

PB:4.65

PE(LYR):-1.10

Loading ...

Overview Company News Filings

Kazia Therapeutics director Ebru Davidson files initial beneficial ownership statement

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Kazia Therapeutics (KZIA)

Kazia Therapeutics Names James Levine CFO

MT Newswires Live

Kazia Therapeutics names James Levine CFO effective June 1

Kazia Therapeutics Appoints James Levine as Chief Financial Officer

THOMSON REUTERS

Kazia expands Phase 1b paxalisib trial in advanced triple-negative breast cancer to 36 patients

Kazia Therapeutics Expands Ongoing Phase 1B Trial of Paxalisib in Advanced Breast Cancer

THOMSON REUTERS

Kazia Therapeutics Ltd - Planned Enrollment in Phase 1B Trial to Increase From 12 to 36 Patients

THOMSON REUTERS

Kazia Therapeutics files beneficial ownership statement for Chief Scientific Officer Sudha Rao

Kazia Therapeutics publishes corporate overview outlining oncology pipeline and development plans

Kazia Therapeutics appoints Sudha Rao as Chief Scientific Officer

Press Release: Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

BRIEF-Kazia Therapeutics Ltd - Buys Global Rights To Setdb1 Platform With $1.39 Million Upfront Payment

Kazia Therapeutics Ltd - Buys Global Rights to Setdb1 Platform With $1.39 Mln Upfront Payment

THOMSON REUTERS

Kazia Therapeutics in-licenses SETDB1 platform from QIMR Berghofer for $1.39 million upfront

Kazia Therapeutics files Form 3 as David Cain named Director, CMC

Kazia Therapeutics Ltd: on March 26, 2026, Bryce Carmine, the Current Chairman of the Board, Notified the Board of His Intent to Retire

THOMSON REUTERS

Kazia Therapeutics Director Steven R. S. Coffey Files Initial Beneficial Ownership Statement

Kazia Therapeutics files initial beneficial ownership statement for CEO John E. Friend II

Kazia Therapeutics’ Program Director Jeremy Simpson files initial beneficial ownership statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/KZIA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KZIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KZIA\",,,,,undefined,":{"symbol":"KZIA","market":"US","secType":"STK","nameCN":"Kazia Therapeutics Limited","latestPrice":13.58,"timestamp":1787947200000,"preClose":16.9,"halted":0,"volume":1179372,"hourTrading":{"tag":"盘后","latestPrice":13.9225,"preClose":13.58,"latestTime":"19:30 EDT","volume":4220,"amount":58068.0692,"timestamp":1787959805741,"change":0.3425,"changeRate":0.025221,"amplitude":0.066642},"delay":0,"changeRate":-0.19644970414201177,"floatShares":9076200,"shares":11426899,"eps":-6.819035,"marketStatus":"Market Closed","change":-3.32,"latestTime":"08-28 16:00:00 EDT","open":15.48,"high":15.5,"low":13.3,"amount":16967396.755518,"amplitude":0.130178,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.819035,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":500,"exchange":"NASDAQ","adjPreClose":16.9,"preHourTrading":{"tag":"盘前","latestPrice":15.48,"preClose":16.9,"latestTime":"09:29 EDT","volume":79393,"amount":1239077.1826260001,"timestamp":1787923799999,"change":-1.42,"changeRate":-0.084024,"amplitude":0.151361},"postHourTrading":{"tag":"盘后","latestPrice":13.9225,"preClose":13.58,"latestTime":"19:30 EDT","volume":4220,"amount":58068.0692,"timestamp":1787959805741,"change":0.3425,"changeRate":0.025221,"amplitude":0.066642},"volumeRatio":4.240932694841565,"impliedVol":1.4548,"impliedVolPercentile":0.2432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KZIA\",,,,,undefined,":{"symbol":"KZIA","floatShares":9076200,"roa":"-25.70%","roe":"-106.90%","lyrEps":-12.38492,"volumeRatio":4.240932694841565,"shares":11426899,"dividePrice":0,"high":15.5,"amplitude":0.130178,"preClose":16.9,"low":13.3,"week52Low":4.86,"pbRate":"4.65","psRate":"113.85","week52High":17.4,"institutionHeld":0.651,"latestPrice":13.58,"eps":-6.819035,"divideRate":0,"volume":1179372,"delay":0,"ttmEps":-6.819035,"open":15.48,"prevYearClose":6.89,"prevWeekClose":13.405,"prevMonthClose":12.62,"prevQuarterClose":14.08,"fiveDayClose":13.405,"twentyDayClose":12.62,"sixtyDayClose":10.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KZIA\",params:#limit:5,,,undefined,":[{"date":"2026-03-16","symbol":"KZIA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773648000000,"name":null,"time":"Pre-MKt","dateTimestamp":1773633600000,"actualEps":null},{"market":"US","date":"2025-04-17","symbol":"KZIA","defaultRemindTime":1744896600000,"type":"split","dateTimestamp":1744862400000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-10-28","symbol":"KZIA","defaultRemindTime":1730122200000,"type":"split","dateTimestamp":1730088000000,"forFactor":10,"toFactor":1,"ratio":10},{"date":"2024-03-27","symbol":"KZIA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711526400000,"name":null,"time":"Pre-MKt","dateTimestamp":1711512000000,"actualEps":null},{"date":"2023-10-30","symbol":"KZIA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1698696000000,"name":null,"time":"Post-Mkt","dateTimestamp":1698638400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KZIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KZIA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1786680000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KZIA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KZIA","date":"2026-08-28","current":-1.991484,"percent":0.100163,"low":-24.844496,"twenty":-7.713718,"median":-1.275331,"eighty":-0.576789,"high":-0.201874,"avg":-4.341816,"sd":6.151841,"marketCap":193114593},"quantilePoints":[{"date":"2021-09-03","current":-23.041898,"twenty":-7.286038,"median":-4.093172,"eighty":-2.408138,"marketCap":144442089.32},{"date":"2021-09-10","current":-22.728403,"twenty":-7.296419,"median":-4.093172,"eighty":-2.408138,"marketCap":141049077.44},{"date":"2021-09-17","current":-22.25816,"twenty":-7.335154,"median":-4.093172,"eighty":-2.408138,"marketCap":136332608},{"date":"2021-09-24","current":-24.766122,"twenty":-7.378041,"median":-4.093172,"eighty":-2.408138,"marketCap":151155366.33},{"date":"2021-10-01","current":-23.982384,"twenty":-7.462667,"median":-4.093172,"eighty":-2.408138,"marketCap":146605704.43},{"date":"2021-10-08","current":-22.806777,"twenty":-7.527319,"median":-4.096601,"eighty":-2.409949,"marketCap":140459059.6},{"date":"2021-10-15","current":-23.041898,"twenty":-7.66309,"median":-4.096601,"eighty":-2.409949,"marketCap":144034696.8},{"date":"2021-10-22","current":-23.355394,"twenty":-7.781029,"median":-4.096601,"eighty":-2.409949,"marketCap":146965175.58},{"date":"2021-10-29","current":-22.728403,"twenty":-8.206083,"median":-4.096601,"eighty":-2.409949,"marketCap":143653060.41},{"date":"2021-11-05","current":-24.609375,"twenty":-8.518821,"median":-4.096601,"eighty":-2.409949,"marketCap":153457106.47},{"date":"2021-11-12","current":-24.295879,"twenty":-10.298084,"median":-4.096601,"eighty":-2.409949,"marketCap":149849083.12},{"date":"2021-11-19","current":-23.982384,"twenty":-10.778381,"median":-4.096601,"eighty":-2.409949,"marketCap":146563151.44},{"date":"2021-11-26","current":-21.63117,"twenty":-10.990809,"median":-4.096601,"eighty":-2.409949,"marketCap":129672466.37},{"date":"2021-12-03","current":-22.414908,"twenty":-11.083168,"median":-4.096601,"eighty":-2.409949,"marketCap":132540516.75},{"date":"2021-12-10","current":-17.869227,"twenty":-11.221708,"median":-4.096601,"eighty":-2.409949,"marketCap":107919625.67},{"date":"2021-12-17","current":-16.853559,"twenty":-11.455877,"median":-4.096601,"eighty":-2.409949,"marketCap":101581620.98},{"date":"2021-12-23","current":-17.872611,"twenty":-11.591456,"median":-4.096601,"eighty":-2.409949,"marketCap":108861226.59},{"date":"2021-12-31","current":-19.67555,"twenty":-11.822046,"median":-4.096601,"eighty":-2.409949,"marketCap":120487673.23},{"date":"2022-01-07","current":-18.656498,"twenty":-12.007673,"median":-4.096601,"eighty":-2.411759,"marketCap":112674276.08},{"date":"2022-01-14","current":-17.559057,"twenty":-12.099126,"median":-4.096601,"eighty":-2.411759,"marketCap":106843200.64},{"date":"2022-01-21","current":-16.22645,"twenty":-12.211487,"median":-4.096601,"eighty":-2.411759,"marketCap":98464234.45},{"date":"2022-01-28","current":-14.423511,"twenty":-12.312042,"median":-4.096601,"eighty":-2.411759,"marketCap":84958897.75},{"date":"2022-02-04","current":-14.854648,"twenty":-12.361629,"median":-4.096601,"eighty":-2.411759,"marketCap":88376133.79},{"date":"2022-02-11","current":-17.167113,"twenty":-12.411676,"median":-4.096601,"eighty":-2.411759,"marketCap":103738783.81},{"date":"2022-02-18","current":-16.853559,"twenty":-12.411676,"median":-4.096601,"eighty":-2.411759,"marketCap":101880562.02},{"date":"2022-02-25","current":-8.436054,"twenty":-12.421685,"median":-4.096601,"eighty":-2.411759,"marketCap":92997383.52},{"date":"2022-03-04","current":-8.046698,"twenty":-12.421685,"median":-4.096601,"eighty":-2.411759,"marketCap":90223808.96},{"date":"2022-03-11","current":-7.61408,"twenty":-12.421685,"median":-4.096601,"eighty":-2.411759,"marketCap":84923799.88},{"date":"2022-03-18","current":-7.657341,"twenty":-12.421685,"median":-4.11788,"eighty":-2.411759,"marketCap":86506462.1},{"date":"2022-03-25","current":-8.392792,"twenty":-12.421685,"median":-4.147516,"eighty":-2.411759,"marketCap":96138786.97},{"date":"2022-04-01","current":-9.128243,"twenty":-12.421685,"median":-4.149137,"eighty":-2.411759,"marketCap":104398752.15},{"date":"2022-04-08","current":-9.863694,"twenty":-12.421685,"median":-4.164704,"eighty":-2.411759,"marketCap":112204560.57},{"date":"2022-04-14","current":-9.733909,"twenty":-12.421685,"median":-4.17509,"eighty":-2.411759,"marketCap":110055464.18},{"date":"2022-04-22","current":-9.387814,"twenty":-12.421685,"median":-4.210686,"eighty":-2.411759,"marketCap":104038032.68},{"date":"2022-04-29","current":-7.267985,"twenty":-12.421685,"median":-4.220674,"eighty":-2.411759,"marketCap":78710705.41},{"date":"2022-05-06","current":-6.97528,"twenty":-12.421685,"median":-4.23077,"eighty":-2.411759,"marketCap":75707332.86},{"date":"2022-05-13","current":-6.185631,"twenty":-12.421685,"median":-4.251907,"eighty":-2.411759,"marketCap":65311187.3},{"date":"2022-05-20","current":-7.019155,"twenty":-12.421685,"median":-4.298656,"eighty":-2.411759,"marketCap":75268113.27},{"date":"2022-05-27","current":-6.844188,"twenty":-12.421685,"median":-4.306423,"eighty":-2.411759,"marketCap":74714930.25},{"date":"2022-06-03","current":-7.107956,"twenty":-12.421685,"median":-4.34538,"eighty":-2.411759,"marketCap":78266237.1},{"date":"2022-06-10","current":-6.88008,"twenty":-12.421685,"median":-4.363747,"eighty":-2.421292,"marketCap":73995154.7},{"date":"2022-06-17","current":-6.575163,"twenty":-12.421685,"median":-4.373415,"eighty":-2.421292,"marketCap":69443299.19},{"date":"2022-06-24","current":-6.001118,"twenty":-12.431695,"median":-4.407052,"eighty":-2.421292,"marketCap":63649254.93},{"date":"2022-07-01","current":-5.591951,"twenty":-12.431695,"median":-4.442308,"eighty":-2.421292,"marketCap":57924623.95},{"date":"2022-07-08","current":-5.660709,"twenty":-12.431695,"median":-4.477564,"eighty":-2.421292,"marketCap":59313253.23},{"date":"2022-07-15","current":-5.112898,"twenty":-12.431695,"median":-4.497241,"eighty":-2.430007,"marketCap":53081227.97},{"date":"2022-07-22","current":-5.021597,"twenty":-12.431695,"median":-4.542589,"eighty":-2.438452,"marketCap":53275034.76},{"date":"2022-07-29","current":-4.65639,"twenty":-12.431695,"median":-4.567511,"eighty":-2.488216,"marketCap":49576264.56},{"date":"2022-08-05","current":-2.282544,"twenty":-12.431695,"median":-4.567511,"eighty":-2.488216,"marketCap":24012261.13},{"date":"2022-08-12","current":-2.282544,"twenty":-12.431695,"median":-4.567511,"eighty":-2.438452,"marketCap":24740525.61},{"date":"2022-08-19","current":-2.451413,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":25687814.32},{"date":"2022-08-26","current":-2.451413,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":25903035.59},{"date":"2022-09-02","current":-1.274908,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":21498048.16},{"date":"2022-09-09","current":-1.396328,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":23545481.29},{"date":"2022-09-16","current":-1.311189,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":21646314.13},{"date":"2022-09-23","current":-1.250703,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":20176115.58},{"date":"2022-09-30","current":-1.11343,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":17680470.3},{"date":"2022-10-07","current":-1.067673,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16832420.37},{"date":"2022-10-14","current":-1.072904,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16471341.64},{"date":"2022-10-21","current":-1.04225,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16264118.39},{"date":"2022-10-28","current":-0.919632,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":14508685.27},{"date":"2022-11-04","current":-0.828719,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":13168797.63},{"date":"2022-11-11","current":-0.656346,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10822510.03},{"date":"2022-11-18","current":-0.662975,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10926711.47},{"date":"2022-11-25","current":-0.603308,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10030499.83},{"date":"2022-12-02","current":-0.576789,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":9642281.61},{"date":"2022-12-09","current":-0.590048,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":9896160.86},{"date":"2022-12-16","current":-0.576789,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":9511326.69},{"date":"2022-12-23","current":-0.497232,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":8215910.04},{"date":"2022-12-30","current":-0.609937,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":10217919.53},{"date":"2023-01-06","current":-0.67955,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":11462784.01},{"date":"2023-01-13","current":-0.895017,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":15343031.72},{"date":"2023-01-20","current":-0.95757,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":16417639.82},{"date":"2023-01-27","current":-0.995872,"twenty":-12.431695,"median":-4.567511,"eighty":-2.451413,"marketCap":17446925.15},{"date":"2023-02-03","current":-0.919267,"twenty":-12.431695,"median":-4.567511,"eighty":-2.446229,"marketCap":15778495.13},{"date":"2023-02-10","current":-0.919267,"twenty":-12.431695,"median":-4.567511,"eighty":-2.421292,"marketCap":15675881.42},{"date":"2023-02-17","current":-0.919267,"twenty":-12.431695,"median":-4.567511,"eighty":-2.409096,"marketCap":15523375.58},{"date":"2023-02-24","current":-0.919267,"twenty":-12.431695,"median":-4.565088,"eighty":-2.388688,"marketCap":15257857.91},{"date":"2023-03-03","current":-1.366426,"twenty":-12.431695,"median":-4.511174,"eighty":-2.37626,"marketCap":23089217.63},{"date":"2023-03-10","current":-1.320878,"twenty":-12.431695,"median":-4.485554,"eighty":-2.353853,"marketCap":21893935.24},{"date":"2023-03-17","current":-1.275331,"twenty":-12.431695,"median":-4.442308,"eighty":-2.338923,"marketCap":21376774.47},{"date":"2023-03-24","current":-1.275331,"twenty":-12.431695,"median":-4.426506,"eighty":-2.314041,"marketCap":21196517.5},{"date":"2023-03-31","current":-1.275331,"twenty":-12.421685,"median":-4.38357,"eighty":-2.300227,"marketCap":21406876.55},{"date":"2023-04-06","current":-1.639711,"twenty":-12.421685,"median":-4.367771,"eighty":-2.287836,"marketCap":27356198.35},{"date":"2023-04-14","current":-1.685259,"twenty":-12.431695,"median":-4.356703,"eighty":-2.269961,"marketCap":28571206.23},{"date":"2023-04-21","current":-1.821901,"twenty":-12.431695,"median":-4.311564,"eighty":-2.264277,"marketCap":30806418.54},{"date":"2023-04-28","current":-1.708032,"twenty":-12.431695,"median":-4.298656,"eighty":-2.239395,"marketCap":28314872.85},{"date":"2023-05-05","current":-1.639711,"twenty":-12.431695,"median":-4.272093,"eighty":-2.238394,"marketCap":27365317.69},{"date":"2023-05-12","current":-1.776354,"twenty":-12.431695,"median":-4.23077,"eighty":-2.214513,"marketCap":29764828.3},{"date":"2023-05-19","current":-1.730806,"twenty":-12.431695,"median":-4.220674,"eighty":-2.18963,"marketCap":28650661.95},{"date":"2023-05-26","current":-1.594164,"twenty":-12.431695,"median":-4.216164,"eighty":-2.131372,"marketCap":25964665.24},{"date":"2023-06-02","current":-1.503069,"twenty":-12.431695,"median":-4.181029,"eighty":-2.093153,"marketCap":24712514.29},{"date":"2023-06-09","current":-1.639711,"twenty":-12.431695,"median":-4.169151,"eighty":-2.040337,"marketCap":27563790.21},{"date":"2023-06-16","current":-1.548616,"twenty":-12.431695,"median":-4.149137,"eighty":-2.030384,"marketCap":26631594.53},{"date":"2023-06-23","current":-1.594164,"twenty":-12.441704,"median":-4.149137,"eighty":-1.990573,"marketCap":26931965.99},{"date":"2023-06-30","current":-1.457521,"twenty":-12.441704,"median":-4.149137,"eighty":-1.965691,"marketCap":24198884.39},{"date":"2023-07-07","current":-1.457521,"twenty":-12.441704,"median":-4.149137,"eighty":-1.940809,"marketCap":24120493.19},{"date":"2023-07-14","current":-1.274574,"twenty":-12.441704,"median":-4.149137,"eighty":-1.915927,"marketCap":21950560.72},{"date":"2023-07-21","current":-1.274574,"twenty":-12.441704,"median":-4.149137,"eighty":-1.891044,"marketCap":21643809.78},{"date":"2023-07-28","current":-1.274574,"twenty":-12.441704,"median":-4.147516,"eighty":-1.876887,"marketCap":21496523.38},{"date":"2023-08-04","current":-1.368987,"twenty":-12.441704,"median":-4.145895,"eighty":-1.866162,"marketCap":22462299.42},{"date":"2023-08-11","current":-1.321781,"twenty":-12.441704,"median":-4.145895,"eighty":-1.84128,"marketCap":21697692.96},{"date":"2023-08-18","current":-1.463493,"twenty":-12.441704,"median":-4.145895,"eighty":-1.818599,"marketCap":23503016.62},{"date":"2023-08-25","current":-1.369074,"twenty":-12.441704,"median":-4.145895,"eighty":-1.755592,"marketCap":22027676.44},{"date":"2023-09-01","current":-1.847817,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":24484233.73},{"date":"2023-09-08","current":-2.021049,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":26353067.86},{"date":"2023-09-15","current":-1.963305,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":25888784.15},{"date":"2023-09-22","current":-1.847817,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":24286108.15},{"date":"2023-09-29","current":-1.905561,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":25009713.33},{"date":"2023-10-06","current":-1.847817,"twenty":-12.441704,"median":-4.145895,"eighty":-1.741751,"marketCap":24002474.77},{"date":"2023-10-13","current":-1.154885,"twenty":-12.441704,"median":-4.145895,"eighty":-1.730806,"marketCap":14966398.81},{"date":"2023-10-20","current":-1.039397,"twenty":-12.441704,"median":-4.145895,"eighty":-1.698405,"marketCap":13448468.74},{"date":"2023-10-27","current":-0.981653,"twenty":-12.461723,"median":-4.145895,"eighty":-1.690641,"marketCap":12665298.2},{"date":"2023-11-03","current":-0.635187,"twenty":-12.461723,"median":-4.145895,"eighty":-1.676652,"marketCap":8341385.4},{"date":"2023-11-10","current":-0.843066,"twenty":-12.461723,"median":-4.145895,"eighty":-1.639711,"marketCap":11079113.85},{"date":"2023-11-16","current":-0.923908,"twenty":-12.461723,"median":-4.145895,"eighty":-1.639711,"marketCap":12219963.16},{"date":"2023-11-24","current":-1.232113,"twenty":-12.461723,"median":-4.145895,"eighty":-1.639711,"marketCap":16544455},{"date":"2023-12-01","current":-0.977856,"twenty":-12.461723,"median":-4.145895,"eighty":-1.594164,"marketCap":13252109},{"date":"2023-12-08","current":-0.981556,"twenty":-12.461723,"median":-4.11076,"eighty":-1.594164,"marketCap":13243494},{"date":"2023-12-15","current":-0.970914,"twenty":-12.461723,"median":-4.11076,"eighty":-1.594164,"marketCap":13332832},{"date":"2023-12-21","current":-0.900502,"twenty":-12.461723,"median":-4.11076,"eighty":-1.592458,"marketCap":12476425},{"date":"2023-12-29","current":-0.989246,"twenty":-12.461723,"median":-4.125,"eighty":-1.548616,"marketCap":13862695},{"date":"2024-01-05","current":-0.901456,"twenty":-12.461723,"median":-4.135447,"eighty":-1.548616,"marketCap":12384007},{"date":"2024-01-12","current":-0.791699,"twenty":-12.461723,"median":-4.135447,"eighty":-1.503069,"marketCap":10782096},{"date":"2024-01-19","current":-0.769505,"twenty":-12.461723,"median":-4.145895,"eighty":-1.463493,"marketCap":10335409},{"date":"2024-01-26","current":-0.844707,"twenty":-12.461723,"median":-4.071317,"eighty":-1.4634,"marketCap":11382812},{"date":"2024-02-02","current":-0.58758,"twenty":-12.461723,"median":-4.001142,"eighty":-1.457135,"marketCap":7882101},{"date":"2024-02-09","current":-0.564955,"twenty":-12.461723,"median":-3.878135,"eighty":-1.418364,"marketCap":7494586},{"date":"2024-02-16","current":-0.614224,"twenty":-12.461723,"median":-3.831621,"eighty":-1.416212,"marketCap":8179987},{"date":"2024-02-23","current":-0.58972,"twenty":-12.461723,"median":-3.831411,"eighty":-1.374525,"marketCap":7895282},{"date":"2024-03-01","current":-0.505287,"twenty":-12.461723,"median":-3.831411,"eighty":-1.368987,"marketCap":6724829},{"date":"2024-03-08","current":-0.427661,"twenty":-12.461723,"median":-3.831411,"eighty":-1.365973,"marketCap":5796903},{"date":"2024-03-15","current":-0.43677,"twenty":-12.461723,"median":-3.831411,"eighty":-1.321815,"marketCap":5889168},{"date":"2024-03-22","current":-0.498231,"twenty":-12.461723,"median":-3.831411,"eighty":-1.320878,"marketCap":6701104},{"date":"2024-03-28","current":-0.807178,"twenty":-12.461723,"median":-3.831411,"eighty":-1.311398,"marketCap":8269616},{"date":"2024-04-05","current":-0.845438,"twenty":-12.461723,"median":-3.831411,"eighty":-1.276404,"marketCap":8783666},{"date":"2024-04-12","current":-0.928185,"twenty":-12.461723,"median":-3.831411,"eighty":-1.275331,"marketCap":9490155},{"date":"2024-04-19","current":-0.902544,"twenty":-12.461723,"median":-3.831411,"eighty":-1.275331,"marketCap":9126366},{"date":"2024-04-26","current":-0.954833,"twenty":-12.461723,"median":-3.831411,"eighty":-1.274908,"marketCap":9752453},{"date":"2024-05-03","current":-0.725,"twenty":-12.461723,"median":-3.831411,"eighty":-1.274574,"marketCap":7447136},{"date":"2024-05-10","current":-0.73121,"twenty":-12.461723,"median":-3.831411,"eighty":-1.239549,"marketCap":7586852},{"date":"2024-05-17","current":-0.739918,"twenty":-12.461723,"median":-3.831411,"eighty":-1.227368,"marketCap":7758202},{"date":"2024-05-24","current":-0.684308,"twenty":-12.461723,"median":-3.831411,"eighty":-1.180978,"marketCap":7117616},{"date":"2024-05-31","current":-0.630805,"twenty":-12.461723,"median":-3.831411,"eighty":-1.142482,"marketCap":6582477},{"date":"2024-06-07","current":-0.641014,"twenty":-12.461723,"median":-3.831411,"eighty":-1.128683,"marketCap":6705058},{"date":"2024-06-14","current":-0.691832,"twenty":-12.461723,"median":-3.831411,"eighty":-1.100941,"marketCap":7213068},{"date":"2024-06-21","current":-0.768927,"twenty":-12.461723,"median":-3.831411,"eighty":-1.085592,"marketCap":8037674},{"date":"2024-06-28","current":-0.633491,"twenty":-12.461723,"median":-3.831831,"eighty":-1.072904,"marketCap":6608754},{"date":"2024-07-05","current":-0.592608,"twenty":-12.461723,"median":-3.831831,"eighty":-1.067673,"marketCap":6260455},{"date":"2024-07-12","current":-3.472596,"twenty":-12.461723,"median":-3.831831,"eighty":-1.052207,"marketCap":36913763},{"date":"2024-07-15","current":-2.505613,"twenty":-12.461723,"median":-3.831831,"eighty":-1.052207,"marketCap":26667217},{"date":"2024-08-02","current":-1.015603,"twenty":-12.468565,"median":-3.934526,"eighty":-1.039174,"marketCap":10396820},{"date":"2024-08-09","current":-1.131852,"twenty":-12.468565,"median":-3.934526,"eighty":-1.027693,"marketCap":11679005},{"date":"2024-08-16","current":-1.102072,"twenty":-12.468565,"median":-3.934526,"eighty":-1.026273,"marketCap":11470451},{"date":"2024-08-23","current":-0.995104,"twenty":-12.468565,"median":-3.934526,"eighty":-1.022854,"marketCap":10484290},{"date":"2024-08-30","current":-1.093789,"twenty":-12.468565,"median":-3.934526,"eighty":-1.015595,"marketCap":11664108},{"date":"2024-09-06","current":-1.157689,"twenty":-12.468565,"median":-3.934526,"eighty":-1.015595,"marketCap":12215286},{"date":"2024-09-13","current":-0.981872,"twenty":-12.468565,"median":-3.934526,"eighty":-1.014085,"marketCap":10323406},{"date":"2024-09-20","current":-0.920424,"twenty":-12.468565,"median":-3.934526,"eighty":-1.004724,"marketCap":9840753},{"date":"2024-09-27","current":-1.00335,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":10856708},{"date":"2024-10-04","current":-1.188007,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":12769443},{"date":"2024-10-11","current":-1.136699,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":12006732},{"date":"2024-10-18","current":-1.490969,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":15698132},{"date":"2024-10-25","current":-1.510511,"twenty":-12.468565,"median":-3.934526,"eighty":-0.995872,"marketCap":15730905},{"date":"2024-10-31","current":-1.642834,"twenty":-12.47672,"median":-3.934526,"eighty":-0.995872,"marketCap":16922639},{"date":"2024-11-08","current":-1.667321,"twenty":-12.484874,"median":-3.959251,"eighty":-0.995872,"marketCap":17458920},{"date":"2024-11-15","current":-1.541747,"twenty":-12.484874,"median":-3.959251,"eighty":-0.995872,"marketCap":15701111},{"date":"2024-11-22","current":-0.944872,"twenty":-12.484874,"median":-3.959251,"eighty":-0.989314,"marketCap":16475739},{"date":"2024-11-29","current":-1.293751,"twenty":-12.484874,"median":-3.888446,"eighty":-0.989314,"marketCap":22515169},{"date":"2024-12-06","current":-1.131503,"twenty":-12.484874,"median":-3.831831,"eighty":-0.989314,"marketCap":19510243},{"date":"2024-12-13","current":-0.935101,"twenty":-12.484874,"median":-3.831411,"eighty":-0.981228,"marketCap":15982721},{"date":"2024-12-20","current":-0.78721,"twenty":-12.484874,"median":-3.737961,"eighty":-0.968918,"marketCap":13195543},{"date":"2024-12-27","current":-0.789276,"twenty":-12.484874,"median":-3.718062,"eighty":-0.95757,"marketCap":13151994},{"date":"2025-01-03","current":-0.457559,"twenty":-12.484874,"median":-3.687691,"eighty":-0.95757,"marketCap":7599413},{"date":"2025-01-10","current":-0.443989,"twenty":-12.493029,"median":-3.564494,"eighty":-0.95757,"marketCap":7359890},{"date":"2025-01-17","current":-0.381761,"twenty":-12.493029,"median":-3.519938,"eighty":-0.954818,"marketCap":6358248},{"date":"2025-01-24","current":-0.380765,"twenty":-12.493029,"median":-3.430825,"eighty":-0.950286,"marketCap":6401798},{"date":"2025-01-31","current":-0.636156,"twenty":-12.493029,"median":-3.183389,"eighty":-0.944606,"marketCap":10619658},{"date":"2025-02-07","current":-0.49819,"twenty":-12.493029,"median":-3.147621,"eighty":-0.936056,"marketCap":8383941},{"date":"2025-02-14","current":-0.311295,"twenty":-12.493029,"median":-3.040316,"eighty":-0.924931,"marketCap":5252259},{"date":"2025-02-21","current":-0.287004,"twenty":-12.493029,"median":-2.754168,"eighty":-0.923908,"marketCap":4912989},{"date":"2025-02-28","current":-0.280424,"twenty":-12.493029,"median":-2.451413,"eighty":-0.919949,"marketCap":4695006},{"date":"2025-03-07","current":-0.277205,"twenty":-12.501183,"median":-2.375858,"eighty":-0.919267,"marketCap":4723512},{"date":"2025-03-14","current":-0.318521,"twenty":-12.501183,"median":-2.282544,"eighty":-0.908486,"marketCap":5365722},{"date":"2025-03-21","current":-0.323944,"twenty":-12.501183,"median":-2.168417,"eighty":-0.900754,"marketCap":5460181},{"date":"2025-03-28","current":-0.314271,"twenty":-12.501183,"median":-1.994749,"eighty":-0.898014,"marketCap":5309829},{"date":"2025-04-04","current":-0.257786,"twenty":-12.501183,"median":-1.963305,"eighty":-0.895017,"marketCap":4388713},{"date":"2025-04-11","current":-0.245199,"twenty":-12.493029,"median":-1.905561,"eighty":-0.870721,"marketCap":4080743},{"date":"2025-04-17","current":-1.157979,"twenty":-12.493029,"median":-1.881668,"eighty":-0.854775,"marketCap":19783306},{"date":"2025-04-25","current":-0.223022,"twenty":-12.501183,"median":-1.847817,"eighty":-0.838925,"marketCap":3820167},{"date":"2025-05-02","current":-0.256851,"twenty":-12.501183,"median":-1.847817,"eighty":-0.827669,"marketCap":4393181},{"date":"2025-05-09","current":-0.21211,"twenty":-12.501183,"median":-1.821901,"eighty":-0.807426,"marketCap":3644217},{"date":"2025-05-16","current":-0.221956,"twenty":-12.501183,"median":-1.776354,"eighty":-0.800489,"marketCap":3800717},{"date":"2025-05-23","current":-0.227118,"twenty":-12.501183,"median":-1.730806,"eighty":-0.795668,"marketCap":3901324},{"date":"2025-05-30","current":-0.244855,"twenty":-12.501183,"median":-1.730806,"eighty":-0.789761,"marketCap":4225503},{"date":"2025-06-06","current":-0.342012,"twenty":-12.501183,"median":-1.685259,"eighty":-0.787597,"marketCap":5974951},{"date":"2025-06-13","current":-0.590795,"twenty":-12.501183,"median":-1.655788,"eighty":-0.777296,"marketCap":10943829},{"date":"2025-06-20","current":-0.543264,"twenty":-12.509338,"median":-1.639711,"eighty":-0.768927,"marketCap":9960114},{"date":"2025-06-27","current":-0.3926,"twenty":-12.509338,"median":-1.639711,"eighty":-0.76103,"marketCap":7299612},{"date":"2025-07-03","current":-0.404205,"twenty":-12.509338,"median":-1.639711,"eighty":-0.759204,"marketCap":7545541},{"date":"2025-07-11","current":-0.621115,"twenty":-12.509338,"median":-1.594381,"eighty":-0.73121,"marketCap":11581008},{"date":"2025-07-18","current":-0.623357,"twenty":-12.509338,"median":-1.594164,"eighty":-0.715356,"marketCap":11480401},{"date":"2025-07-25","current":-0.593254,"twenty":-12.509338,"median":-1.594164,"eighty":-0.707088,"marketCap":11133865},{"date":"2025-08-01","current":-0.512794,"twenty":-12.509338,"median":-1.594164,"eighty":-0.696124,"marketCap":9367650},{"date":"2025-08-08","current":-0.498877,"twenty":-12.509338,"median":-1.548616,"eighty":-0.691832,"marketCap":9211149},{"date":"2025-08-15","current":-0.501215,"twenty":-12.509338,"median":-1.548616,"eighty":-0.684308,"marketCap":9244685},{"date":"2025-08-22","current":-0.447282,"twenty":-12.509338,"median":-1.503069,"eighty":-0.662975,"marketCap":8160363},{"date":"2025-08-29","current":-0.466145,"twenty":-12.509338,"median":-1.463493,"eighty":-0.656346,"marketCap":8641042},{"date":"2025-09-05","current":-0.489255,"twenty":-12.509338,"median":-1.4634,"eighty":-0.652939,"marketCap":9043471},{"date":"2025-09-12","current":-0.48198,"twenty":-12.509338,"median":-1.457521,"eighty":-0.647962,"marketCap":9110542},{"date":"2025-09-19","current":-0.459727,"twenty":-12.509338,"median":-1.431745,"eighty":-0.636156,"marketCap":8641042},{"date":"2025-09-26","current":-0.440581,"twenty":-12.509338,"median":-1.416284,"eighty":-0.630805,"marketCap":8193899},{"date":"2025-10-03","current":-0.377089,"twenty":-12.509338,"median":-1.411973,"eighty":-0.618501,"marketCap":7053683},{"date":"2025-10-10","current":-0.431199,"twenty":-12.509338,"median":-1.369074,"eighty":-0.611352,"marketCap":8026220},{"date":"2025-10-17","current":-0.423198,"twenty":-12.509338,"median":-1.366426,"eighty":-0.603308,"marketCap":7813827},{"date":"2025-10-24","current":-0.407347,"twenty":-12.509338,"median":-1.365973,"eighty":-0.59245,"marketCap":7534362},{"date":"2025-10-31","current":-0.461136,"twenty":-12.509338,"median":-1.321781,"eighty":-0.589121,"marketCap":8585149},{"date":"2025-11-07","current":-0.456526,"twenty":-12.509338,"median":-1.320878,"eighty":-0.576789,"marketCap":8383935},{"date":"2025-11-14","current":-0.60058,"twenty":-12.509338,"median":-1.311189,"eighty":-0.576789,"marketCap":8149184},{"date":"2025-11-21","current":-1.024803,"twenty":-12.468565,"median":-1.280696,"eighty":-0.576789,"marketCap":13722815},{"date":"2025-11-28","current":-1.4312,"twenty":-12.461723,"median":-1.275331,"eighty":-0.576789,"marketCap":19355040},{"date":"2025-12-05","current":-1.791162,"twenty":-12.411676,"median":-1.275331,"eighty":-0.576789,"marketCap":24546961},{"date":"2025-12-12","current":-1.738946,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":23996581},{"date":"2025-12-19","current":-1.335479,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":18309317},{"date":"2025-12-26","current":-1.058046,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":14676808},{"date":"2026-01-02","current":-5.435019,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":75075569},{"date":"2026-01-09","current":-5.334687,"twenty":-12.361629,"median":-1.275331,"eighty":-0.576789,"marketCap":73876975},{"date":"2026-01-16","current":-5.499054,"twenty":-12.311582,"median":-1.275331,"eighty":-0.576789,"marketCap":76383126},{"date":"2026-01-23","current":-5.390625,"twenty":-12.311582,"median":-1.275331,"eighty":-0.576789,"marketCap":76274163},{"date":"2026-01-30","current":-4.588381,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"marketCap":66467484},{"date":"2026-02-06","current":-4.246852,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"marketCap":61237256},{"date":"2026-02-13","current":-3.814062,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"marketCap":56007028},{"date":"2026-02-20","current":-4.669524,"twenty":-12.211487,"median":-1.275331,"eighty":-0.576789,"marketCap":68210894},{"date":"2026-02-27","current":-6.560958,"twenty":-11.911205,"median":-1.275331,"eighty":-0.576789,"marketCap":96432334},{"date":"2026-03-06","current":-6.412815,"twenty":-9.733909,"median":-1.275331,"eighty":-0.576789,"marketCap":92727589},{"date":"2026-03-13","current":-5.944124,"twenty":-9.5176,"median":-1.275331,"eighty":-0.576789,"marketCap":87279435},{"date":"2026-03-20","current":-6.194432,"twenty":-9.387814,"median":-1.275331,"eighty":-0.576789,"marketCap":90386771},{"date":"2026-03-27","current":-5.272379,"twenty":-9.171505,"median":-1.275331,"eighty":-0.576789,"marketCap":82959286},{"date":"2026-04-02","current":-5.209747,"twenty":-8.868672,"median":-1.275331,"eighty":-0.576789,"marketCap":82045134},{"date":"2026-04-10","current":-6.449646,"twenty":-8.392792,"median":-1.275331,"eighty":-0.576789,"marketCap":103984780},{"date":"2026-04-17","current":-7.634827,"twenty":-8.219745,"median":-1.275331,"eighty":-0.576789,"marketCap":124781737},{"date":"2026-04-24","current":-8.27124,"twenty":-7.916912,"median":-1.275331,"eighty":-0.576789,"marketCap":135065946},{"date":"2026-05-01","current":-9.512823,"twenty":-7.916912,"median":-1.275331,"eighty":-0.576789,"marketCap":155862902},{"date":"2026-05-08","current":-9.272441,"twenty":-7.916912,"median":-1.275331,"eighty":-0.576789,"marketCap":153234715},{"date":"2026-05-15","current":-9.595429,"twenty":-7.916912,"median":-1.275331,"eighty":-0.576789,"marketCap":158034013},{"date":"2026-05-22","current":-9.260938,"twenty":-7.916912,"median":-1.275331,"eighty":-0.576789,"marketCap":150492259},{"date":"2026-05-29","current":-8.869343,"twenty":-7.847694,"median":-1.275331,"eighty":-0.576789,"marketCap":144778810},{"date":"2026-06-05","current":-8.001447,"twenty":-7.830389,"median":-1.275331,"eighty":-0.576789,"marketCap":130266648},{"date":"2026-06-12","current":-8.984474,"twenty":-7.789134,"median":-1.275331,"eighty":-0.576789,"marketCap":143293313},{"date":"2026-06-18","current":-10.164638,"twenty":-7.789134,"median":-1.275331,"eighty":-0.576789,"marketCap":162833310},{"date":"2026-06-26","current":-10.082724,"twenty":-7.762541,"median":-1.275331,"eighty":-0.576789,"marketCap":159062434},{"date":"2026-07-02","current":-9.680036,"twenty":-7.762541,"median":-1.275331,"eighty":-0.576789,"marketCap":153006177},{"date":"2026-07-10","current":-9.369975,"twenty":-7.762541,"median":-1.275331,"eighty":-0.576789,"marketCap":148321149},{"date":"2026-07-17","current":-9.391477,"twenty":-7.762541,"median":-1.275331,"eighty":-0.576789,"marketCap":149920914},{"date":"2026-07-24","current":-9.37473,"twenty":-7.762541,"median":-1.275331,"eighty":-0.576789,"marketCap":149006762},{"date":"2026-07-31","current":-9.165809,"twenty":-7.713718,"median":-1.275331,"eighty":-0.576789,"marketCap":146492845},{"date":"2026-08-07","current":-8.784582,"twenty":-7.713718,"median":-1.275331,"eighty":-0.576789,"marketCap":140893664},{"date":"2026-08-14","current":-9.377118,"twenty":-7.713718,"median":-1.275331,"eighty":-0.576789,"marketCap":150949335},{"date":"2026-08-21","current":-9.622123,"twenty":-7.713718,"median":-1.275331,"eighty":-0.576789,"marketCap":156205709},{"date":"2026-08-28","current":-11.774557,"twenty":-7.713718,"median":-1.275331,"eighty":-0.576789,"marketCap":193114593}],"updateTime":1788114487593},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KZIA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640045180","title":"Kazia Therapeutics director Ebru Davidson files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640045180","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640045180?lang=en_us&edition=fundamental","pubTime":"2026-06-04 08:20","pubTimestamp":1780532432,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics director Ebru Davidson filed an initial Form 3 disclosing ADS options covering 77,000 shares with exercise prices of $0.33 and $8.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLbvnz5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640900125","title":"Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Kazia Therapeutics (KZIA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640900125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640900125?lang=en_us&edition=fundamental","pubTime":"2026-06-03 22:21","pubTimestamp":1780496480,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Elanco Animal Health (ELAN) and Kazia Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elanco-animal-health-elan-and-kazia-therapeutics-kzia-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elanco-animal-health-elan-and-kazia-therapeutics-kzia-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","KZIA","BK4588","ELAN","BK4007","BK4137","BK4139","BK4585","XLV","BK4561","LU1941712264.USD","LABU","LU1941712348.USD","HCSG","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948823","title":"Kazia Therapeutics Names James Levine CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948823","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640948823?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:06","pubTimestamp":1780401968,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics (KZIA) said Tuesday that it has appointed James Levine as its chief financial officer, starting June 1.Levine was most recently the CFO of Cardiff Oncology, Kazia said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LENZ","BK4139","BK4539","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917774","title":"Kazia Therapeutics names James Levine CFO effective June 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917774","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917774?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:30","pubTimestamp":1780399859,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics appointed James Levine as chief financial officer, effective June 1, 2026.Levine most recently served as CFO of Cardiff Oncology.He previously held CFO roles at Cidara Therapeutics, leading a USD 568 million licensing collaboration with Mundipharma.He also led a USD 780 million global partnership with Janssen Pharmaceuticals, following 12 years at Goldman Sachs as a managing director.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLLQfTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","LU0345770308.USD","KZIA","LU1032466523.USD","IE00B19Z3581.USD","BK4532","LU1718418525.SGD","LU2896262040.SGD","SG9999013999.USD","IE00B19Z3B42.SGD","BK4568","IE00B3T34201.USD","LU1267930813.SGD","IE00BDGV0183.EUR","BK4559","LU0234570918.USD","LU1430594728.SGD","LU1121112475.USD","LU0070217475.USD","LU2505996509.AUD","LU2456880835.USD","JNJ","LU0545562505.USD","LU1894683264.USD","LU1066051225.USD","SG9999002224.SGD","LU1066051811.HKD","IE00BBT3K403.USD","IE00B3PB1722.GBP","LU0203345920.USD","LU0912757837.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU0053666078.USD","IE00BFTCPJ56.SGD","LU0345769128.USD","IE00B4R5TH58.HKD","LU1032955483.USD","CRDF","LU1043141396.HKD","BK4588","LU1059921491.USD","LU2403377893.USD","LU1551013425.SGD","LU0210528500.USD","LU0964807845.USD","LU1221951129.SGD","IE0000B7K699.USD","LU1023059063.AUD","IE0034235303.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917768","title":"Kazia Therapeutics Appoints James Levine as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917768","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917768?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:30","pubTimestamp":1780399801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUA9GL5CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638519279","title":"Kazia expands Phase 1b paxalisib trial in advanced triple-negative breast cancer to 36 patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2638519279","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638519279?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:31","pubTimestamp":1779795076,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics expanded its Phase 1b paxalisib combination trial in advanced triple-negative breast cancer, lifting planned enrollment to 36 from 12.The move follows encouraging safety, tolerability, and early clinical activity signals, supporting continued dose refinement and a clearer efficacy read.Scientific results were not presented at ASCO 2026; abstracts were withdrawn for intellectual property reasons, not due to safety concerns.Additional clinical updates are expected through 2026 into 2027, a key catalyst window for the program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via PR Newswire  on May 26, 2026, and is solely responsibl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL792BWc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638519298","title":"Kazia Therapeutics Expands Ongoing Phase 1B Trial of Paxalisib in Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2638519298","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638519298?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:30","pubTimestamp":1779795007,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA6RBVWG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638192675","title":"Kazia Therapeutics Ltd - Planned Enrollment in Phase 1B Trial to Increase From 12 to 36 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2638192675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638192675?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:30","pubTimestamp":1779795007,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA6RBVWG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636863416","title":"Kazia Therapeutics files beneficial ownership statement for Chief Scientific Officer Sudha Rao","url":"https://stock-news.laohu8.com/highlight/detail?id=2636863416","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636863416?lang=en_us&edition=fundamental","pubTime":"2026-05-20 01:07","pubTimestamp":1779210479,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics filed an initial Form 3 for Sudha Rao in her role as chief scientific officer, dated April 13, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL8JnCfw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630344956","title":"Kazia Therapeutics publishes corporate overview outlining oncology pipeline and development plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2630344956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630344956?lang=en_us&edition=fundamental","pubTime":"2026-04-28 08:57","pubTimestamp":1777337826,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics outlined strategy to broaden oncology pipeline beyond lead brain-penetrant PI3K/mTOR inhibitor paxalisib into immuno-oncology protein degradation and epigenetic modulation.Paxalisib has been evaluated in more than 550 adult and pediatric patients across Phase 1-3 trials and expanded access programs.Company highlighted January 2026 clinical updates in metastatic TNBC, including one complete metabolic response under expanded access and two partial responses in ongoing Phase 1b study.Kazia reported cash and cash equivalents of about USD 46 million, with expected runway into 2029, excluding additional or expanded trials.Pipeline buildout includes NDL2 intracellular PD-L1 protein degrader and MSETC SETDB1 inhibitor, with IND-enabling studies slated to start in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL8y1nC7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627028430","title":"Kazia Therapeutics appoints Sudha Rao as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627028430","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627028430?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:16","pubTimestamp":1776255384,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics (KZIA) appointed Sudha Rao as Chief Scientific Officer, or CSO. Dr. Rao has more than 20 years of experience spanning pharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-appoints-sudha-rao-as-chief-scientific-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-appoints-sudha-rao-as-chief-scientific-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KZIA","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627281696","title":"Press Release: Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2627281696","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627281696?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:00","pubTimestamp":1776254400,"startTime":"0","endTime":"0","summary":"SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics , a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the appointment of Dr. Sudha Rao as Chief Scientific Officer .Dr. Rao is the scientific originator of the epigenetic framework underlying paxalisib and a pioneer in next-generation therapeutic platforms, including PD-L1 protein degradation and SETDB1-targeted chromatin modulation. Her appointment brings deep expertise in translational epigenetics, AI-guided epi-drug discovery capability, liquid and spatial epigenetic clinical biomarker precision medicine platforms, and early clinical development into Kazia's executive leadership as the Company advances its integrated oncology platform strategy.Dr. John Friend, CEO of Kazia Therapeutics, commented: \"Dr. Rao is a leading translational epigenetics scientist, a breast cancer researcher, and the lead inventor behind the intellectual property linking PI3K/mTOR inhi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYTNYN87.SGD","DBB","IE00B12V2V27.USD","BK4526","BK4531","BK4007","BK4571","KZIA","LU0269904917.USD","LU1023057109.AUD","BK4535","LU0359202008.SGD","BK4563","BK4139","BK4509","TME","LU0359201612.USD","LU0456842615.SGD","BK4552","BK4108","01698","LU0828238088.HKD","LU2039709279.SGD","SG9999011746.SGD","LU0509642566.USD","LENZ","BK4565","BK4539","IE00BYQNZ168.SGD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627466644","title":"BRIEF-Kazia Therapeutics Ltd - Buys Global Rights To Setdb1 Platform With $1.39 Million Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2627466644","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627466644?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:09","pubTimestamp":1776114582,"startTime":"0","endTime":"0","summary":"BRIEF-Kazia Therapeutics Ltd - Buys Global Rights To Setdb1 Platform With $1.39 Million Upfront PaymentApril 13 (Reuters) - Kazia Therapeutics Ltd KZIA.O:KAZIA THERAPEUTICS LTD - BUYS GLOBAL RIGHTS TO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627466688","title":"Kazia Therapeutics Ltd - Buys Global Rights to Setdb1 Platform With $1.39 Mln Upfront Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2627466688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627466688?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:06","pubTimestamp":1776114415,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nFWN40W0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627146668","title":"Kazia Therapeutics in-licenses SETDB1 platform from QIMR Berghofer for $1.39 million upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2627146668","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627146668?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:06","pubTimestamp":1776114386,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics in-licensed global rights to first-in-class SETDB1-targeted epigenetic drug development platform from QIMR Berghofer.Agreement includes lead candidate MSETC, an AI-discovered bicyclic peptide designed to target a disease-associated nuclear SETDB1 complex.Financial terms include upfront payment of approximately USD 1.39 million.Deal adds tiered revenue-sharing tied to development progress, with no clinical or regulatory milestone obligations.Program remains in preclinical development with defined path toward IND-enabling studies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL394vYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624651997","title":"Kazia Therapeutics files Form 3 as David Cain named Director, CMC","url":"https://stock-news.laohu8.com/highlight/detail?id=2624651997","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624651997?lang=en_us&edition=fundamental","pubTime":"2026-04-01 21:21","pubTimestamp":1775049664,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Form 3 identified David Cain, Director, CMC, holding options covering 100,000 ADSs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL7ZtgZc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624594578","title":"Kazia Therapeutics Ltd: on March 26, 2026, Bryce Carmine, the Current Chairman of the Board, Notified the Board of His Intent to Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2624594578","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624594578?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:07","pubTimestamp":1775038053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620950512","title":"Kazia Therapeutics Director Steven R. S. Coffey Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620950512","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620950512?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:18","pubTimestamp":1773875936,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics reported an initial statement of beneficial ownership for director Steven Coffey. The filing shows direct ownership of 16,000 ordinary shares. It also reports ADS options covering 1,000 ADSs at an exercise price of USD 0.33 and 75,000 ADSs at an exercise price of USD 8.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5nbdDh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620055293","title":"Kazia Therapeutics files initial beneficial ownership statement for CEO John E. Friend II","url":"https://stock-news.laohu8.com/highlight/detail?id=2620055293","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620055293?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:36","pubTimestamp":1773873382,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics reported an initial statement of beneficial ownership for John Friend, Chief Executive Officer. The filing listed a direct option to buy 30,000 American Depositary Shares at USD 0.377 per share. It also disclosed a direct option to buy 500,000 American Depositary Shares at USD 6.58 per share. In addition, John Friend reported direct options to buy 3 million ordinary shares at USD 0.13 per share and 1 million ordinary shares at USD 0.11 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Mar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLc3nxGB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620293782","title":"Kazia Therapeutics’ Program Director Jeremy Simpson files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293782","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620293782?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:33","pubTimestamp":1773873197,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics reported an initial statement of beneficial ownership by Jeremy Simpson, an officer with the title Program Director. The filing listed 280,000 ordinary share options with an exercise price of USD 0.11 per share. It also listed 100,000 ordinary share options with an exercise price of USD 0.67 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6tLmM4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}